Positive and negative regulation of type II TGF‐β receptor signal transduction by autophosphorylation on multiple serine residues
暂无分享,去创建一个
H. Lodish | K. Luo | H F Lodish | K Luo | Harvey F. Lodish
[1] H. Lodish,et al. The types II and III transforming growth factor-beta receptors form homo-oligomers , 1994, The Journal of cell biology.
[2] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[3] K. Luo,et al. Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. , 1991, Methods in enzymology.
[4] Elizabeth J. Goldsmith,et al. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.
[5] D. Riddle,et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.
[6] J. Massagué,et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.
[7] L. Mathews,et al. Expression cloning of an activin receptor, a predicted transmembrane serine kinase , 1991, Cell.
[8] J. Massagué,et al. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex , 1995, Molecular and cellular biology.
[9] T. Pawson,et al. The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.
[10] T. Hunter,et al. Mutation of Tyr697, a GRB2‐binding site, and Tyr721, a PI 3‐kinase binding site, abrogates signal transduction by the murine CSF‐1 receptor expressed in Rat‐2 fibroblasts. , 1993, The EMBO journal.
[11] D. Riddle,et al. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development , 1993, Nature.
[12] C. Chan,et al. The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. , 1994, The Journal of biological chemistry.
[13] K. Kinzler,et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.
[14] V. Baldin,et al. Effects of TGF‐β1 (transforming growth factor‐β1) on the cell cycle regulation of human breast adenocarcinoma (MCF‐7) cells , 1995 .
[15] Jonathan A. Cooper,et al. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. , 1992, The EMBO journal.
[16] J. Zheng,et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[17] K. Miyazono,et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.
[18] L. Mathews,et al. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. , 1992, Science.
[19] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[20] H. Lodish,et al. Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] Tony Pawson,et al. Structure and function of SH2 domains , 1994, Journal of Cell Science.
[22] H. Lodish,et al. Signaling by chimeric erythropoietin‐TGF‐beta receptors: homodimerization of the cytoplasmic domain of the type I TGF‐beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. , 1996, The EMBO journal.
[23] H. Lodish,et al. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma , 1996, Molecular and cellular biology.
[24] K. Miyazono,et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Weinberg,et al. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Kurten,et al. Association of Epidermal Growth Factor Receptors with Coated Pit Adaptins via a Tyrosine Phosphorylation-regulated Mechanism (*) , 1995, The Journal of Biological Chemistry.
[27] J. Willson,et al. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells , 1994 .
[28] Jeffrey L. Wrana,et al. TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.
[29] H. Lodish,et al. The specificity of the transforming growth factor beta receptor kinases determined by a spatially addressable peptide library. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Weinberg,et al. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.
[31] J. Massagué,et al. Loss of receptors for transforming growth factor beta in human T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Massagué,et al. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.
[33] P. Allen,et al. Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.
[34] M. Kamps. Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. , 1991, Methods in enzymology.
[35] M. Sporn,et al. The Transforming Growth Factor-βs , 1991 .
[36] K. Miyazono,et al. Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.
[37] H. Lodish,et al. GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor and Activin-A (*) , 1995, The Journal of Biological Chemistry.
[38] 김성진. Transforming Growth Factor-βs , 1996 .
[39] J. Massagué,et al. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.
[40] J. Massagué,et al. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors , 1992, Cell.
[41] R. Derynck,et al. Homomeric interactions between type II transforming growth factor-beta receptors. , 1994, The Journal of biological chemistry.
[42] G. Nolan,et al. Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. L. Gustafson,et al. A transforming growth factor beta type I receptor that signals to activate gene expression. , 1994, Science.
[44] S. Hubbard,et al. Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.
[45] M. Sporn,et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. , 1994, Proceedings of the National Academy of Sciences of the United States of America.